Abstract
Steroids are currently the most frequently accepted agents for idiopathic sudden sensorineural hearing loss (ISSNHL). However, the therapeutic effect of steroids is not always satisfactory. In this pilot study, we evaluated whether systemic treatment with Ginkgo biloba extract (EGb761) has an additive therapeutic effect in patients receiving a systemic steroid due to ISSNHL. A multicenter, randomized, double-blind clinical trial was performed. Fifty-six patients with ISSNHL were allocated to either EGb761 or placebo. In both groups, methylprednisolone was administered for 14 days. EGb761 was infused intravenously for 5 days in the EGb761 group, while the same amount of normal saline was infused in the placebo group. For the efficacy evaluation, pure-tone audiometry, speech audiometry, tinnitus handicap inventory (THI) and short form-36 health (SF-36) survey outcomes were obtained before administration and on days 3, 5, 14 and 28 of administration. Twenty-four patients in each group completed the study protocol. There was no difference in hearing loss between the two groups before treatment. At day 28, air conduction threshold values in the placebo and EGb761 groups were 34.63 ± 28.90 and 23.84 ± 25.42 dB, respectively (p = 0.082). Speech discrimination scores in the placebo and EGb761 groups were 69.17 ± 40.89 and 87.48 ± 28.65 %, respectively (p = 0.050). THI and SF-36 scores in the placebo and EGb761 groups were similar. Although a combination of steroid and EGb761 for initial treatment did not show better pure tone threshold, compared with steroid alone, speech discrimination was significantly improved in combination therapy. Further studies will be needed to know if addition of EGb761 actually improves the outcome of ISSNHL treatment.
Similar content being viewed by others
References
Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, Brown SR, Fife TD, Ford P, Ganiats TG, Hollingsworth DB, Lewandowski CA, Montano JJ, Saunders JE, Tucci DL, Valente M, Warren BE, Yaremchuk KL, Robertson PJ (2012) Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 146:S1–S35
Byl FM (1977) Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope 87:817–825
Byl FM Jr (1984) Sudden hearing loss: 8 years’ experience and suggested prognostic table. Laryngoscope 94:647–661
Klemm E, Deutscher A, Mosges R (2009) A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss. Laryngorhinootologie 88:524–527
Lazarini PR, Camargo AC (2006) Idiopathic sudden sensorineural hearing loss: etiopathogenic aspects. Braz J Otorhinolaryngol 72:554–561
Mattox DE, Simmons FB (1977) Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86:463–480
Shin SO (2007) Clinical Characteristics of Sudden Deafness and Therapeutic Approach Otorhinolaryngology Seoul Symposium. pp 108–117
Carlsson PI, Hall M, Lind KJ, Danermark B (2011) Quality of life, psychosocial consequences, and audiological rehabilitation after sudden sensorineural hearing loss. Int J Audiol 50:139–144
Chiossoine-Kerdel JA, Baguley DM, Stoddart RL, Moffat DA (2000) An investigation of the audiologic handicap associated with unilateral sudden sensorineural hearing loss. Am J Otol 21:645–651
Mosges R, Koberlein J, Erdtracht B, Klingel R (2008) Quality of life in patients with idiopathic sudden hearing loss: comparison of different therapies using the Medical Outcome Short Form (36) Health Survey questionnaire. Otol Neurotol 29:769–775
Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 106:772–776
Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 133:573–581
Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 133:582–586
Nosrati-Zarenoe R, Hultcrantz E (2012) Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otol Neurotol 33:523–531
Wei BP, Mubiru S, O’Leary S (2006) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 1:Cd003998
Wei BP, Stathopoulos D, O’Leary S (2013) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 7:Cd003998
Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134:940–945
Kellerhals B, Hippert F, Pfaltz CR (1971) Treatment of acute acoustic trauma with low molecular weight dextran. Pract Otorhinolaryngol (Basel) 33:260–264
Singleton GT (1971) Cervical sympathetic chain block in sudden deafness. Laryngoscope 81:734–736
McCabe BF (2007) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 116:875–879
Fowler EP (1950) Sudden deafness. Ann Otol Rhinol Laryngol 59:980–987
Hallberg OE (1956) Sudden deafness of obscure origin. Laryngoscope 66:1237–1267
Haberkamp TJ, Tanyeri HM (1999) Management of idiopathic sudden sensorineural hearing loss. Am J Otol 20:587–592 (discussion 593–595)
Hoffmann F, Beck C, Schutz A, Offermann P (1994) Ginkgo extract EGb 761 (tenobin)/HAES versus naftidrofuryl (Dusodril)/HAES. A randomized study of therapy of sudden deafness. Laryngorhinootologie 73:149–152
Reisser CH, Weidauer H (2001) Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study. Acta Otolaryngol 121:579–584
Byun JY, Cho Y, Chu H, Park S, Han GC, Cheon BC, Shin JE, Chung JW, Chai SW, Choi JY (2011) Standardization for a Korean Version of Chronic Ear Survey: translation and verification of validity and reliability. Korean J Otorhinolaryngol Head Neck Surg 54:755–760
Cinamon U, Bendet E, Kronenberg J (2001) Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 258:477–480
Labus J, Breil J, Stutzer H, Michel O (2010) Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope 120:1863–1871
Cole RR, Jahrsdoerfer RA (1988) Sudden hearing loss: an update. Am J Otol 9:211–215
Shikowitz MJ (1991) Sudden sensorineural hearing loss. Med Clin North Am 75:1239–1250
Thurmond M, Amedee RG (1998) Sudden sensorineural hearing loss: etiologies and treatments. J La State Med Soc 150:200–203
Fisch U, Nagahara K, Pollak A (1984) Sudden hearing loss: circulatory. Am J Otol 5:488–491
Miller JM, Dengerink H (1988) Control of inner ear blood flow. Am J Otolaryngol 9:302–316
Suckfull M (2002) Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 360:1811–1817
Agarwal L, Pothier DD (2009) Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 4:Cd003422
Choi SJ, Kim SW, Lee JB, Lim HJ, Kim YJ, Tian C, So HS, Park R, Choung YH (2013) Gingko biloba extracts protect auditory hair cells from cisplatin-induced ototoxicity by inhibiting perturbation of gap junctional intercellular communication. Neuroscience 244:49–61
Huang X, Whitworth CA, Rybak LP (2007) Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 28:828–833
Tian CJ, Kim YJ, Kim SW, Lim HJ, Kim YS, Choung YH (2013) A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways. Cell Death Dis 4:e509
Nevado J, Sanz R, Sanchez-Rodriguez C, Garcia-Berrocal JR, Martin-Sanz E, Gonzalez-Garcia JA, Esteban-Sanchez J, Ramirez-Camacho R (2010) Ginkgo biloba extract (EGb761) protects against aging-related caspase-mediated apoptosis in rat cochlea. Acta Otolaryngol 130:1101–1112
Tziridis K, Korn S, Ahlf S (2014) Protective effects of Ginkgo biloba extract EGb 761 against noise trauma-induced hearing loss and tinnitus development. Neural Plast 2014:427298
Lamm K, Arnold W (2000) The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO(2) and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res 141:199–219
Jang CH, Cho YB, Kim JS, Cho SW, Yang HC, Jung KH, Kim JY, Choi CH, Lim Y, Park H, Kang SI (2011) Effect of Ginkgo biloba extract on endotoxin-induced labyrinthitis. Int J Pediatr Otorhinolaryngol 75:905–909
Dubreuil C (1986) Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline. Presse Med 15:1559–1561
Acknowledgments
This study was funded by YuYu Pharma, Inc., Seoul, Korea.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
No potential conflict of interest relevant to this article was reported.
Additional information
J.-W. Koo and M. Y. Chang contributed equally to this work as first authors.
J. W. Chung and E.-K. Goh contributed equally as corresponding authors to the completion of this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Koo, JW., Chang, M.Y., Yun, SC. et al. The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial. Eur Arch Otorhinolaryngol 273, 2433–2441 (2016). https://doi.org/10.1007/s00405-015-3821-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3821-4